查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1527078

2024 年核子醫學放射性同位素全球市場報告

Nuclear Medicine Radioisotopes Global Market Report 2024
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

核醫學放射性同位素市場規模預計在未來幾年將強勁成長。 2028年，將以8.7%的複合年成長率成長至114.4億美元。預計的成長可能與幾個因素有關，包括醫療保健成本的上升、醫療保健基礎設施的持續擴張、環境永續性意識的增強、教育宣傳活動和意識提升計劃以及醫療旅遊業的快速成長。這段時期的顯著趨勢包括新型放射性同位素的開發、生產和供應鏈方法的進步、微流體和實驗室晶片技術的整合、人工智慧在放射性藥物開發中的使用以及奈米技術的應用。

心血管疾病盛行率的增加預計將在未來幾年推動核醫放射性同位素市場的成長。由於久坐的生活方式、不良的飲食習慣、肥胖和老化等因素，心血管疾病（包括影響心臟和血管的疾病）呈現上升趨勢。核醫放射性同位素透過提供對心臟功能、灌注和組織活力的詳細了解，在心血管疾病的診斷、評估和治療中發揮重要作用，這對於準確的診斷和有效的治療計劃至關重要。例如，根據美國疾病管制與預防中心的數據，美國成年人心臟疾病的盛行率從美國的 4.6% 上升到 2021 年的 4.9%。因此，心血管疾病病例的增加正在推動對核醫學放射性同位素的需求。

核醫放射性同位素市場的主要參與企業正在利用緊湊型低能量迴旋加速器等創新技術來提高放射性同位素的生產和可用性，並確保提供更有效率、更容易獲得的診斷和治療開拓。緊湊型低能量迴旋加速器是一種小型粒子加速器，用於生產用於醫學成像和核醫學治療的放射性同位素。例如，2022 年 1 月，IBA 宣布推出 Cyclone Key，這是一種新型加速器，旨在改善診斷解決方案的獲取並實現放射性藥物的內部生產。 Cyclone Key 的特點包括緊湊高效的設計、全自動化操作、多種同位素生產能力、易於安裝和操作、水冷卻、自屏蔽和高性能，使其用途廣泛且可靠。

目錄

第1章執行概述

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球核子醫學放射性同位素市場：促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 全球核醫放射性同位素市場表現：規模與成長，2018-2023
  • 全球核醫放射性同位素市場預測：規模與成長，2023-2028 年、2033 年

第6章 市場細分

  • 全球核醫放射性同位素市場：依類型、實際與預測，2018-2023、2023-2028、2033
  • Technetium-99m (Tc-99m)
  • 鉈~201 (Tl~201)
  • 碘 (I-123)
  • 氟18
  • 銣-82 (Rb-82)
  • 碘 131 (I-131)
  • 鎦-177 (Lu-177)
  • 鐳 223 (Ra-223) 和Alpharadin
  • 錒-225 (Ac-225)
  • 其他
  • 全球核醫放射性同位素市場：按應用、性能和預測，2018-2023、2023-2028、2033
  • 腫瘤學
  • 心臟病學
  • 甲狀腺
  • 神經病學
  • 其他
  • 全球核醫放射性同位素市場：依最終使用者、效能與預測，2018-2023、2023-2028、2033
  • 醫院
  • 診斷中心
  • 專科診所
  • 教育及研究機構
  • 其他

第 7 章 區域/國家分析

  • 全球核醫放射性同位素市場：按地區、績效及預測，2018-2023、2023-2028、2033
  • 全球核醫放射性同位素市場：依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 核子醫學放射性同位素市場：競爭格局
  • 核子醫學放射性同位素市場：公司簡介
    • Cardinal Health Inc.
    • Bayer AG
    • Siemens Healthineers AG
    • GE HealthCare Technologies
    • BWX Technologies Inc.

第31章 其他大型創新企業

  • Mallinckrodt Pharmaceuticals
  • Bracco Imaging SpA
  • Lantheus Holdings Inc.
  • Curium Pharma
  • Australian Nuclear Science and Technology Organization（ANSTO）Health
  • Eckert & Ziegler Strahlen
  • NorthStar Medical Radioisotopes
  • NTP Radioisotopes
  • Shine Medical Technologies Inc.
  • Jubilant DraxImage Inc.
  • Isotopia Molecular Imaging Ltd.
  • EczacIbasI-Monrol Nuclear Products
  • International Isotopes Inc.
  • Polatom Sp. z oo
  • Radiomedix Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來展望與潛力分析

第36章附錄

簡介目錄
Product Code: r18683

Radioactive isotopes, known as nuclear medicine radioisotopes, play crucial roles in diagnosing, treating, and researching diverse medical conditions. These isotopes emit radiation that specialized equipment detects and images, aiding in diagnosis, or administer therapeutic radiation doses to specific tissues. Integral to modern medical practices, nuclear medicine radioisotopes offer essential diagnostic information and therapeutic solutions, thereby enhancing patient outcomes.

Among the primary types of nuclear medicine radioisotopes are technetium-99m (Tc-99m), thallium-201 (Tl-201), iodine (I-123), fluorine-18, rubidium-82 (Rb-82), iodine-131 (I-131), lutetium-177 (Lu-177), radium-223 (Ra-223) and alpharadin, actinium-225 (Ac-225), and others. Technetium-99m (Tc-99m), widely employed in nuclear medicine imaging, facilitates the diagnosis of various medical conditions across oncology, cardiology, thyroid, neurology, and other fields. End users including hospitals, diagnostic centers, specialty clinics, as well as educational and research institutes, benefit from its applications.

The nuclear medicine radioisotopes research report is one of a series of new reports from The Business Research Company that provides nuclear medicine radioisotopes market statistics, including the nuclear medicine radioisotopes industry's global market size, regional shares, competitors with a nuclear medicine radioisotopes market share, detailed nuclear medicine radioisotopes market segments, market trends and opportunities, and any further data you may need to thrive in the nuclear medicine radioisotopes industry. This nuclear medicine radioisotopes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nuclear medicine radioisotopes market size has grown strongly in recent years. It will grow from $7.57 billion in 2023 to $8.21 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historic period can be ascribed to various factors, including the discovery of radioactivity, the emergence of nuclear medicine, its therapeutic applications, advancements in clinical research, and the rising demand from patients.

The nuclear medicine radioisotopes market size is expected to see strong growth in the next few years. It will grow to $11.44 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. The projected growth can be linked to several factors such as increased healthcare expenditures, the ongoing expansion of healthcare infrastructure, heightened awareness regarding environmental sustainability, educational campaigns, awareness programs, and the burgeoning medical tourism sector. Notable trends expected during this period encompass the development of novel radioisotopes, advancements in production and supply chain methodologies, the integration of microfluidics and lab-on-a-chip technology, the utilization of artificial intelligence in radiopharmaceutical development, and the application of nanotechnology.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the nuclear medicine radioisotope market in the coming years. Cardiovascular diseases, which encompass conditions affecting the heart and blood vessels, are on the rise due to factors such as sedentary lifestyles, poor dietary habits, obesity, and aging populations. Nuclear medicine radioisotopes play a crucial role in diagnosing, evaluating, and managing cardiovascular diseases by providing detailed insights into cardiac function, perfusion, and tissue viability, which are essential for accurate diagnosis and effective treatment planning. For example, according to the Centers for Disease Control and Prevention, the prevalence of coronary heart disease among adults in the United States increased from 4.6% in 2020 to 4.9% in 2021. Hence, the growing cases of cardiovascular diseases are fueling the demand for nuclear medicine radioisotopes.

Key players in the nuclear medicine radioisotopes market are concentrating on developing innovative products such as compact low-energy cyclotrons to enhance the production and availability of radioisotopes, thereby ensuring more efficient and accessible diagnostic and therapeutic options. Compact low-energy cyclotrons are small particle accelerators used to create radioisotopes for medical imaging and treatments in nuclear medicine. For instance, in January 2022, IBA introduced Cyclone Key, a new accelerator designed to provide increased access to diagnostic solutions and enable in-house production of radiopharmaceuticals. Cyclone Key offers features such as a compact and efficient design, fully automated operation, multiple isotope production capabilities, ease of installation and operation, water cooling, self-shielding, and high performance, making it versatile and reliable.

In April 2024, Telix Pharmaceuticals Limited acquired ARTMS, a Canada-based company specializing in novel radioisotope technology. This acquisition aimed to bolster Telix Pharmaceuticals' nuclear medicine capabilities, optimize production procedures, and expand its range of diagnostic and therapeutic radiopharmaceuticals. ARTMS's innovative radioisotope technology holds promise for advancing nuclear medicine applications and addressing the growing demand for radiopharmaceuticals in the diagnosis and treatment of various medical conditions, including cardiovascular diseases.

Major companies operating in the nuclear medicine radioisotopes market are Cardinal Health Inc., Bayer Aktiengesellschaft, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., EczacIbasI-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation

North America was the largest region in the nuclear medicine radioisotopes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the nuclear medicine radioisotopes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nuclear medicine radioisotopes market consists of sales of yttrium-90, indium-111, carbon-11, samarium-153, and strontium-89. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nuclear Medicine Radioisotopes Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nuclear medicine radioisotopes market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nuclear medicine radioisotopes ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nuclear medicine radioisotopes market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Technetium-99m (Tc-99m); Thallium-201 (Tl-201); Iodine (I-123); Fluorine-18; Rubidium-82 (Rb-82); Iodine-131 (I-131); Lutetium-177 (Lu-177); Radium-223 (Ra-223) And Alpharadin; Actinium-225 (Ac-225); Other Types
  • 2) By Application: Oncology; Cardiology; Thyroid; Neurology; Other Applications
  • 3) By End-User: Hospitals; Diagnostic Centers; Specialty Clinics; Education And Research Institutes; Other End-Users
  • Companies Mentioned: Cardinal Health Inc.; Bayer AG; Siemens Healthineers AG; GE HealthCare Technologies; BWX Technologies Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Nuclear Medicine Radioisotopes Market Characteristics

3. Nuclear Medicine Radioisotopes Market Trends And Strategies

4. Nuclear Medicine Radioisotopes Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Nuclear Medicine Radioisotopes Market Size and Growth

  • 5.1. Global Nuclear Medicine Radioisotopes Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Nuclear Medicine Radioisotopes Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Nuclear Medicine Radioisotopes Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Nuclear Medicine Radioisotopes Market Segmentation

  • 6.1. Global Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Technetium-99m (Tc-99m)
  • Thallium-201 (Tl-201)
  • Iodine (I-123)
  • Fluorine-18
  • Rubidium-82 (Rb-82)
  • Iodine-131 (I-131)
  • Lutetium-177 (Lu-177)
  • Radium-223 (Ra-223) And Alpharadin
  • Actinium-225 (Ac-225)
  • Other Types
  • 6.2. Global Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Oncology
  • Cardiology
  • Thyroid
  • Neurology
  • Other Applications
  • 6.3. Global Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Specialty Clinics
  • Education And Research Institutes
  • Other End-Users

7. Nuclear Medicine Radioisotopes Market Regional And Country Analysis

  • 7.1. Global Nuclear Medicine Radioisotopes Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Nuclear Medicine Radioisotopes Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Nuclear Medicine Radioisotopes Market

  • 8.1. Asia-Pacific Nuclear Medicine Radioisotopes Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Nuclear Medicine Radioisotopes Market

  • 9.1. China Nuclear Medicine Radioisotopes Market Overview
  • 9.2. China Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Nuclear Medicine Radioisotopes Market

  • 10.1. India Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Nuclear Medicine Radioisotopes Market

  • 11.1. Japan Nuclear Medicine Radioisotopes Market Overview
  • 11.2. Japan Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Nuclear Medicine Radioisotopes Market

  • 12.1. Australia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Nuclear Medicine Radioisotopes Market

  • 13.1. Indonesia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Nuclear Medicine Radioisotopes Market

  • 14.1. South Korea Nuclear Medicine Radioisotopes Market Overview
  • 14.2. South Korea Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Nuclear Medicine Radioisotopes Market

  • 15.1. Western Europe Nuclear Medicine Radioisotopes Market Overview
  • 15.2. Western Europe Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Nuclear Medicine Radioisotopes Market

  • 16.1. UK Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Nuclear Medicine Radioisotopes Market

  • 17.1. Germany Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Nuclear Medicine Radioisotopes Market

  • 18.1. France Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Nuclear Medicine Radioisotopes Market

  • 19.1. Italy Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Nuclear Medicine Radioisotopes Market

  • 20.1. Spain Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Nuclear Medicine Radioisotopes Market

  • 21.1. Eastern Europe Nuclear Medicine Radioisotopes Market Overview
  • 21.2. Eastern Europe Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Nuclear Medicine Radioisotopes Market

  • 22.1. Russia Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Nuclear Medicine Radioisotopes Market

  • 23.1. North America Nuclear Medicine Radioisotopes Market Overview
  • 23.2. North America Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Nuclear Medicine Radioisotopes Market

  • 24.1. USA Nuclear Medicine Radioisotopes Market Overview
  • 24.2. USA Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Nuclear Medicine Radioisotopes Market

  • 25.1. Canada Nuclear Medicine Radioisotopes Market Overview
  • 25.2. Canada Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Nuclear Medicine Radioisotopes Market

  • 26.1. South America Nuclear Medicine Radioisotopes Market Overview
  • 26.2. South America Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Nuclear Medicine Radioisotopes Market

  • 27.1. Brazil Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Nuclear Medicine Radioisotopes Market

  • 28.1. Middle East Nuclear Medicine Radioisotopes Market Overview
  • 28.2. Middle East Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Nuclear Medicine Radioisotopes Market

  • 29.1. Africa Nuclear Medicine Radioisotopes Market Overview
  • 29.2. Africa Nuclear Medicine Radioisotopes Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Nuclear Medicine Radioisotopes Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Nuclear Medicine Radioisotopes Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Nuclear Medicine Radioisotopes Market Competitive Landscape And Company Profiles

  • 30.1. Nuclear Medicine Radioisotopes Market Competitive Landscape
  • 30.2. Nuclear Medicine Radioisotopes Market Company Profiles
    • 30.2.1. Cardinal Health Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. GE HealthCare Technologies
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. BWX Technologies Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Nuclear Medicine Radioisotopes Market Other Major And Innovative Companies

  • 31.1. Mallinckrodt Pharmaceuticals
  • 31.2. Bracco Imaging S.p.A.
  • 31.3. Lantheus Holdings Inc.
  • 31.4. Curium Pharma
  • 31.5. Australian Nuclear Science and Technology Organization (ANSTO) Health
  • 31.6. Eckert & Ziegler Strahlen
  • 31.7. NorthStar Medical Radioisotopes
  • 31.8. NTP Radioisotopes
  • 31.9. Shine Medical Technologies Inc.
  • 31.10. Jubilant DraxImage Inc.
  • 31.11. Isotopia Molecular Imaging Ltd.
  • 31.12. EczacIbasI-Monrol Nuclear Products
  • 31.13. International Isotopes Inc.
  • 31.14. Polatom Sp. z o.o.
  • 31.15. Radiomedix Inc.

32. Global Nuclear Medicine Radioisotopes Market Competitive Benchmarking

33. Global Nuclear Medicine Radioisotopes Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Nuclear Medicine Radioisotopes Market

35. Nuclear Medicine Radioisotopes Market Future Outlook and Potential Analysis

  • 35.1 Nuclear Medicine Radioisotopes Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Nuclear Medicine Radioisotopes Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Nuclear Medicine Radioisotopes Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer